Evidence mapPaperPMID 41340001Full record

ArticleActa neuropathologica2025

Nucleolar aggregation of key neuropathological proteins in the postmortem neurodegenerative brain.

Guinevere F Lourenco, Maria Elizabeth Torres-Pacheco, YuHong Fu, Hongyun Li, Heather McCann, Claire E Shepherd, Jillian J Kril, Glenda M Halliday

Abstract read
In one paragraph

Article in Acta neuropathologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guinevere F LourencoNeuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0002-2182-2949
Maria Elizabeth Torres-PachecoNeuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0001-8041-8420
YuHong FuNeuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0003-4539-2039
Hongyun LiNeuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0003-3332-3132
Heather McCannNeuroscience Research Australia, Sydney, Australia.ORCID http://orcid.org/0000-0002-8474-8969
Claire E ShepherdNeuroscience Research Australia, Sydney, Australia.ORCID http://orcid.org/0000-0002-0399-3218
Jillian J KrilNeuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.ORCID http://orcid.org/0000-0001-9407-8674
Glenda M HallidayNeuroscience, School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia. glenda.halliday@sydney.edu.au.ORCID http://orcid.org/0000-0003-0422-8398

Funding

National Health and Medical Research Council 1132524, 1095127, 1176607
6 · The paper itself

Abstract

Nucleolar disturbances have long been implicated in neurodegenerative diseases but, to date, aggregation and immobilization of proteins into nucleolar bodies have only been reported in vitro and in cell models, and only for amyloid β (Aβ). In model systems, these bodies have been shown to coordinate local nuclear protein synthesis with potential to seed diagnostic neuropathologies. Here we confirm the presence of nucleolar aggregates of amyloid nature in postmortem brain tissue from controls and patients with neurodegenerative pathologies and demonstrate the nucleolar sequestration of fibrillation-prone proteins associated with neurodegenerative diseases (Aβ, tau, α-synuclein, TDP-43, and FUS, but not prion or peptide repeats). We identified nucleolar bodies ranging from multiple small foci to a centralized, large amyloid aggresome, that appear to represent progressive stages of protein immobilization from liquid-like foci to the formation of nucleolar aggresomes. Neurons with nucleolar aggresomes were more vulnerable to neurodegeneration, decreasing in number with increasing duration of disease. Nucleolar aggresomes with phosphorylated tau correlated with increasing amounts of neuropathology, while phosphorylated TDP-43 in nucleolar aggresomes distinguished cases with limbic-predominant age-related TDP-43 encephalopathy. Nucleolar aggresomes containing α-synuclein occurred in a large proportion of aged controls with limited neuronal loss (potentially asserting neuroprotection). Other fibrillation-prone proteins were either absent (prion and peptide repeats) or found less commonly in nucleolar aggresomes (Aβ and FUS), and amyloidogenic nuclear proteins not screened in this study may also occur in nucleolar aggresomes. Our data do not support the concept that proteins in aggresomes seed diagnostic neuropathologies as there were no associations between their presence in nucleoli aggresomes and their cytoplasmic or extracellular accumulation. Assessment of neurons with and without phosphorylated tau or α-synuclein aggresomes showed that phosphorylated tau ameliorated the increased DNA levels found in AD. Collectively, our observations establish that nucleolar sequestration of amyloidogenic proteins is a common molecular mechanism in the brain, representing a novel contribution to the understanding of nucleolar protein aggregation in the context of neuroprotection and neurodegeneration during brain aging.

Indexed as

BrainCell NucleolusNeurodegenerative DiseasesProtein Aggregation, PathologicalAgedAged, 80 and overalpha-SynucleinAmyloid beta-PeptidesDNA-Binding ProteinsFemaleHumansMaleMiddle AgedNeuronsRNA-Binding Protein FUStau Proteinsalpha-SynucleinAmyloid beta-PeptidesDNA-Binding ProteinsRNA-Binding Protein FUSTARDBP protein, humantau ProteinsNeurodegenerationNucleolar aggregationNucleolar aggresomesNucleolar amyloid bodiesNucleolar cavitiesNucleolar sequestrationNucleolus

Identifiers

PMID41340001
PMCPMC12675744

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.